MN SF4058 | 2023-2024 | 93rd Legislature
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on February 22 2024 - 25% progression
Action: 2024-02-22 - Referred to Health and Human Services
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 22 2024 - 25% progression
Action: 2024-02-22 - Referred to Health and Human Services
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases
Title
Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-02-22 | Senate | Referred to Health and Human Services |
2024-02-22 | Senate | Introduction and first reading |
Same As/Similar To
HF3664 (Similar To) 2024-03-18 - Author added Hemmingsen-Jaeger